Dietary conjugated nonadecadienoic acid prevents adult-onset obesity in nescient basic helix-loop-helix 2 knockout mice

Journal of Nutritional Biochemistry

Volumn 24, Issue 3, 2013, Pages 556-566

  Kim, Jun Ho ^a   Park, Yooheon ^a   Kim, Daeyoung ^a   Good, Deborah J ^b   Park, Yeonhwa ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adult onset obesity; CNA; Conjugated nonadecadienoic acid; Energy expenditure; Nhlh2; Voluntary activity

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; CONJUGATED NONADECADIENOIC ACID; FAS ANTIGEN; FATTY ACID BINDING PROTEIN 4; FATTY ACID DERIVATIVE; GLUCOSE; HELIX LOOP HELIX PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DARKNESS; DIET SUPPLEMENTATION; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART; IMMOBILIZATION; KIDNEY; KNOCKOUT MOUSE; LIGHT; LIPID DIET; LIVER; LUNG GAS EXCHANGE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; OBESITY; ORGAN WEIGHT; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; SPLEEN; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VOLUNTARY MOVEMENT; WEIGHT GAIN; WILD TYPE;

ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BODY COMPOSITION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, UNSATURATED; FEMALE; GLUCOSE TOLERANCE TEST; LEPTIN; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE, SKELETAL; OBESITY; RNA, MESSENGER; TRIGLYCERIDES; WEIGHT GAIN;

ANIMALIA; MUS;

EID: 84875500397     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.02.005     Document Type: Article

References (64)

1. Hill J.O., Saris W.H.M. Energy expenditure in physical activity. Handbook of obesity 1998, 457-474. M. Dekker, New York, NY. G.A. Bray, C. Bouchard, W.P.T. James (Eds.).
2. Kotz C.M., Billington C.J., Levine A.S. Obesity and aging. Clin Geriatr Med 1999, 15:391-412.
3. Nonogaki K., Abdallah L., Goulding E.H., et al. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2C receptor mutant mice. Diabetes 2003, 52:315-320.
4. Jakicic J.M., Otto A.D. Physical activity considerations for the treatment and prevention of obesity. Am J Clin Nutr 2005, 82:226S-229S.
5. Coyle C.A., Jing E., Hosmer T., et al. Reduced voluntary activity precedes adult-onset obesity in Nhlh2 knockout mice. Physiol Behav 2002, 77:387-402.
6. Good D.J., Porter F.D., Mahon K.A., et al. Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet 1997, 15:397-401.
7. Good D.J., Coyle C.A., Fox D.L. Nhlh2: a basic helix-loop-helix transcription factor controlling physical activity. Exerc Sport Sci Rev 2008, 36:187-192.
8. Park Y., Storkson J.M., Albright K.J., et al. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34:235-241.
9. Park Y., Albright K.J., Liu W., et al. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997, 32:853-858.
10. Park Y., Albright K.J., Storkson J.M., et al. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 1999, 34:243-248.
11. DeLany J.P., Blohm F., Truett A.A., et al. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 1999, 276:R1172-R1179.
12. Pariza M.W., Park Y., Xu X., et al. Speculation on the mechanisms of action of conjugated linoleic acid. Advances in conjugated linoleic acid research 2003, 251-258. AOCS Press, Champaign, IL. J.L. Sebedio, W.W. Christie, R. Adlof (Eds.).
13. Larsen T.M., Toubro S., Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003, 44:2234-2241.
14. Jahreis G., Kraft J., Tischendorf F., et al. Conjugated linoleic acids: physiological effects in animal and man with special regard to body composition. Eur J Lipid Sci Tech 2000, 102:695-703.
15. Riserus U., Smedman A., Basu S., et al. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004, 79:1146S-1148S.
16. Gaullier J.M., Halse J., Hoye K., et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004, 79:1118-1125.
17. Terpstra A.H. Effect of conjugated linoleic acid on body composition and plasma lipid in humans: an overview of the literature. Am J Clin Nutr 2004, 79:352-361.
18. Malpuech-Brugere C., Verboeket-van de Venne W.P., Mensink R.P., et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004, 12:591-598.
19. Park Y., Pariza M.W. The effects of dietary conjugated nonadecadienoic acid (CNA) on body composition in mice. Biochim Biophys Acta 2001, 1533:171-174.
20. Park Y., Storkson J.M., Albright K.J., et al. Biological activities of conjugated fatty acids: conjugated eicosadienoic (conj. 20:2delta(c11, t13/t12, c14)), eicosatrienoic (conj. 20:3delta(c8, t12, c14)), and heneicosadienoic (conj. 21:2delta(c12, t14/c13, t15)) acids and other metabolites of conjugated linoleic acid. Biochim Biophys Acta 2005, 1687:120-129.
21. Park Y., Park Y. Conjugated nonadecadienoic acid is more potent than conjugated linoleic acid on body fat reduction. J Nutr Biochem 2010, 21:764-773.
22. Wittert G.A., Turnbull H., Hope P. Exogenously administered leptin leads to weight loss and increased physical activity in the marsupial Sminthopsis crassicaudata. Physiol Behav 2005, 85:613-620.
23. Choi C.S., Savage D.B., Abu-Elheiga L., et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 2007, 104:16480-16485.
24. Choi S.J., Yablonka-Reuveni Z., Kaiyala K.J., et al. Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice. Am J Physiol Endocrinol Metab 2011, 300:E1031-E1037.
25. Wargent E., Sennitt M.V., Stocker C., et al. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Lipids Health Dis 2005, 4:3.
26. Milliken G.A., Johnson D.E. Analysis of messy data volume III: analysis of covariance 2002, 123-160. Chapman and Hall/CRC Press, Boca Raton, FL.
27. Newberry E.P., Xie Y., Kennedy S.M., et al. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 2006, 44:1191-1205.
28. Wankhade U.D., Vella K.R., Fox D.L., et al. Deletion of Nhlh2 results in a defective torpor response and reduced beta adrenergic receptor expression in adipose tissue. PLoS One 2010, 5(8):e12324.
29. Rayner V.D. The sympathetic nervous system in white adipose tissue regulation. Proc Nutr Soc 2001, 60:357-364.
30. Freeman D.A., Lewis D.A., Kauffman A.S., et al. Reduced leptin concentrations are permissive for display of torpor in Siberian hamsters. Am J Physiol 2004, 287:R97-R103.
31. Swoap S.J., Gutilla M.J., Liles L.C., et al. The full expression of fasting-induced torpor requires β3-adrenergic receptor signaling. J Neurosci 2006, 26(1):241-245.
32. Hofbauer K.G. Molecular pathways to obesity. Int J Obes 2002, 26(2):S18-S27.
33. Swoap S.J., Weinshenker D. Norepinephrine controls both torpor initiation and emergence via distinct mechanisms in the mouse. PLoS One 2008, 3(12):e4038.
34. Himms-Hagen J. Food restriction increases torpor and improves brown adipose tissue thermogenesis in ob/ob mice. Am J Physiol 1985, 248(5):E531-E539.
35. Morton G.J., Kaiyala K.J., Fisher J.D., et al. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab 2011, 300:E392-E401.
36. Giroud S., Blanc S., Aujard F., et al. Chronic food shortage and seasonal modulations of daily torpor and locomotor activity in the grey mouse lemur (Microcebus murinus). Am J Physiol-Reg I 2008, 294:R1958-R1967.
37. Genin F., Perret M. Daily hypothermia in captive grey mouse lemurs (Microcebus murinus): effects of photoperiod and food restriction. Compar Biochem Physiol Part B 2003, 136:71-81.
38. Plaisance E.P., Henagan T.M., Echlin H., et al. Role of β-adrenergic receptors in the hyperphagic and hypermetabolic responses to dietary methionine restriction. Am J Physiol-Reg I 2010, 299:R740-R750.
39. Hogberg H., Engblom L., Ekdahl A., et al. Temperature dependence of O2 consumption; opposite effects of leptin and etomoxir on respiratory quotient in mice. Obesity (Silver Spring) 2006, 14:673-682.
40. Laposky A.D., Shelton J., Bass J., et al. Altered sleep regulation in leptin-deficient mice. Am J Physiol-Reg I 2006, 290:R894-R903.
41. Wankhade U.D., Good D.J. Melanocortin 4 receptor is a transcriptional target of nescient helix-loop-helix-2. Mol Cell Endocrinol 2011, 341:39-47.
42. Takahashi S., Krueger J.M. Inhibition of tumor necrosis factor prevents warming-induced sleep responses in rabbits. Am J Physiol 1997, 272(4):R1325-R1329.
43. Fang J., Wang Y., Krueger J.M. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci 1997, 17:5949-5955.
44. Albertia A., Sarchielli P., Gallinella E., et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 2003, 12:305-311.
45. Uthgenannt D., Schoolmann D., Pietrowsky R., et al. Effects of sleep on the production of cytokines in humans. Psychosom Med 1995, 57:97-104.
46. Takahashi S., Kapas L., Fang J., et al. An anti-tumor necrosis factor antibody suppresses sleep in rats and rabbits. Brain Res 1995, 690:241-244.
47. West D.B., Blohm F.Y., Truett A.A., et al. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr 2000, 130:2471-2477.
48. Park Y., Albright K.J., Storkson J.M., et al. Conjugated linoleic acid (CLA) prevents body fat accumulation and weight gain in an animal model. J Food Sci 2007, 72(8):S612-S617.
49. Pariza M.W., Park Y., Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001, 40:283-298.
50. Wahle K.W., Heys S.D., Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res 2004, 43:553-587.
51. Marshall S., Garvey W.T., Traxinger R.R. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J 1991, 5:3031-3036.
52. Prada P.O., Ropelle E.R., Mourão R.H., et al. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes 2009, 58(12):2910-2919.
53. Kirwan J.P., Mouzon D.H., Lepercq J., et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
54. Park Y., Pariza M.W. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res Int 2007, 40:311-323.
55. Dumke C.L., Gazdag A.C., Fechner K., et al. Skeletal muscle glucose transport in conjugated linoleic acid (CLA) fed mice. Med Sci Sports Exerc 2000, 32:S226.
56. Park Y., Pariza M.W. Bioactivities and potential mechanisms of action for conjugated fatty acids. Food Sci Biotechnol 2009, 18:586-593.
57. Dilzer A., Park Y. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr 2012, 52:488-513.
58. Tarnopolsky M., Zimmer A., Paikin J., et al. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS One 2007, 2:e991.
59. Watras A.C., Buchholz A.C., Close R.N., et al. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond) 2007, 31:481-487.
60. Racine N.M., Watras A.C., Carrel A.L., et al. Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr 2010, 91:1157-1164.
61. Sluijs I., Plantinga Y., de Roos B., et al. Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 2010, 91:175-183.
62. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004, 79:1132S-1136S.
63. Clement L., Poirier H., Niot I., et al. Dietary trans-10, cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 2002, 43:1400-1409.
64. Poirier H., Niot I., Clement L., et al. Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 2005, 87:73-79.